4-(2-Furyl)-3,4-dihydrobenzo[h]quinoline-2,5,6(1H)-trione

ID: ALA4782588

PubChem CID: 162664183

Max Phase: Preclinical

Molecular Formula: C17H11NO4

Molecular Weight: 293.28

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C1CC(c2ccco2)C2=C(N1)c1ccccc1C(=O)C2=O

Standard InChI:  InChI=1S/C17H11NO4/c19-13-8-11(12-6-3-7-22-12)14-15(18-13)9-4-1-2-5-10(9)16(20)17(14)21/h1-7,11H,8H2,(H,18,19)

Standard InChI Key:  NMYYFAYVDCBNGC-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 22 25  0  0  0  0  0  0  0  0999 V2000
   28.6302   -2.3053    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.9173   -1.8912    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.6313   -3.1266    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.9171   -3.5369    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.9174   -4.3565    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.6301   -4.7721    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3402   -4.3577    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3416   -3.5319    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.2109   -3.1284    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.2115   -2.3089    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.5026   -1.8984    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.7927   -2.3104    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.7961   -3.1330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.5055   -3.5357    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.6293   -5.5934    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.3378   -1.8924    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   27.9139   -1.0699    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   30.0452   -3.1233    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.7923   -3.4543    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.3381   -2.8461    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.9282   -2.1391    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.1292   -2.3105    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 10  2  1  0
  9  4  1  0
  3  1  1  0
  1  2  1  0
  3  4  2  0
  3  8  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
  6 15  2  0
  1 16  2  0
  2 17  2  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 18  2  0
  8 18  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4782588

    ---

Associated Targets(Human)

NQO1 Tchem Quinone reductase 1 (1746 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 293.28Molecular Weight (Monoisotopic): 293.0688AlogP: 2.06#Rotatable Bonds: 1
Polar Surface Area: 76.38Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 12.55CX Basic pKa: CX LogP: 1.23CX LogD: 1.23
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.82Np Likeness Score: -0.02

References

1. Wu LQ,Ma X,Zhang C,Liu ZP.  (2020)  Design, synthesis, and biological evaluation of 4-substituted-3,4-dihydrobenzo[h]quinoline-2,5,6(1H)-triones as NQO1-directed antitumor agents.,  198  [PMID:32464425] [10.1016/j.ejmech.2020.112396]

Source